Volume 17, Number 5—May 2011
Research
Evolution of New Genotype of West Nile Virus in North America
Table 3
Group† | NY99 | Group 1 | Group 2 | Group 3 | Group 4 | Group 5 | Group 6 |
---|---|---|---|---|---|---|---|
NY99 | 0.1–0.2 | 0.1–0.2 | 0.1 | 0.1–0.2 | 0.2 | 0.2–0.3 | |
Group 1 | 0.3–0.4 | 0.1–0.3 | 0.1–0.3 | 0.1–0.3 | 0.2–0.3 | 0.2–0.4 | |
Group 2 | 0.3 | 0.3–0.4 | 0.1–0.2 | 0.2–0.3 | 0.2–0.3 | 0.2–0.3 | |
Group 3 | 0.3 | 0.1–0.4 | 0.2–0.3 | 0.1–0.3 | 0.2–0.3 | 0.2–0.3 | |
Group 4 | 0.5–0.6 | 0.5–0.7 | 0.5–0.6 | 0.5–0.6 | 0.2–0.3 | 0.2–0.3 | |
Group 5 | 0.5–0.7 | 0.5–0.8 | 0.4–0.7 | 0.4–0.7 | 0.7–1.0 | 0.3 | |
Group 6 | 0.4–0.5 | 0.4–0.6 | 0.4–0.5 | 0.4–0.5 | 0.7–0.8 | 0.6–0.8 |
*Amino acid sequence divergence is shown above the diagonal, and nucleotide sequence divergence is shown in below the diagonal.
†Group 1: bird 114 (2002), bird 1171 (2003), bird 1153 (2003); group 2: bird 1519 (2003), v4369 (2003), v4095 (2003), bird 1881 (2003), v4380 (2003); group 3: bird 1576 (2003), bird 1175 (2003), TX2003; group 4: TX6376 (2006), M20141 (2009), M20140 (2009), M37906 (2009), M39488 (2009), M20122 (2009), M37102 (2009); group 5: M12214 (2005), M19433 (2007), TX6647 (2007), TX7558 (2008); group 6: M6019 (2006), TX5810 (2006).
Page created: August 14, 2011
Page updated: August 14, 2011
Page reviewed: August 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.